Vincerx Pharma, Inc. Depreciation
Vincerx Pharma, Inc. reported Depreciation of $52.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2024-03-29
- Vincerx Pharma, Inc. depreciation for fiscal 2023 was $52.00M, a 3.70% decline from fiscal 2022.
- Vincerx Pharma, Inc. depreciation for fiscal 2022 was $54.00M, a 116.00% increase from fiscal 2021.
- Vincerx Pharma, Inc. depreciation for fiscal 2021 was $25.00M.
| Period end | Depreciation 12 month |
|---|---|
| 2023-12-31 | $52.00M 10-K · filed 2024-03-29 |
| 2022-12-31 | $54.00M 10-K · filed 2024-03-29 |
| 2021-12-31 | $25.00M 10-K · filed 2023-03-28 |